Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$305,910.00
Agreement Date:
Oct 1, 2014 - Jun 30, 2015
Description:
A phase 1 Randomized, Single-Centre, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSV¿-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Subjects
Organization:
Canadian Institutes of Health Research
Location:
Halifax, Nova Scotia, CA B3H 3J5
Reference Number:
236-2014-2015-Q3-00070
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2014-15 to 2015-16)

Recipient's Legal Name:
HALPERIN, Scott A
Research Organization:
Dalhousie University (Nova Scotia)